Acquisition of Epithelial–mesenchymal Transition and Cancer Stem Cell Phenotypes Is Associated With Activation of the PI3K/Akt/mTOR Pathway in Prostate Cancer Radioresistance

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2013.407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-κB Pathway in Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

MiR-206 Inhibits HGF-induced Epithelial-Mesenchymal Transition and Angiogenesis in Non-Small Cell Lung Cancer via C-Met /PI3k/ Akt/mTOR Pathway

Oncotarget
Oncology
2016English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Epithelial–mesenchymal Transition and Gastric Cancer Stem Cell

Tumor Biology
MedicineCancer Research
2017English

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs
Cancer ResearchToxicologyOncologyPharmaceuticsPharmacology
2016English

Activation of PI3K-AKT Pathway in Oral Epithelial Dysplasia and Early Cancer of Tongue

The Bulletin of Tokyo Dental College
Medicine
2009English

Correlation Between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women

PLoS ONE
Multidisciplinary
2015English

Non-Small Cell Lung Cancer Cells Survived Ionizing Radiation Treatment Display Cancer Stem Cell and Epithelial-Mesenchymal Transition Phenotypes

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy